Home/Filings/4/0001438133-25-000088
4//SEC Filing

Morrison Susan 4

Accession 0001438133-25-000088

CIK 0001438133other

Filed

May 18, 8:00 PM ET

Accepted

May 19, 6:06 PM ET

Size

26.2 KB

Accession

0001438133-25-000088

Insider Transaction Report

Form 4
Period: 2025-05-15
Transactions
  • Award

    Common Stock

    2025-05-15$15.64/sh+1,359$21,25532,548 total
  • Exercise/Conversion

    Common Stock

    2025-05-15+16232,710 total
  • Exercise/Conversion

    Common Stock

    2025-05-15+1,50334,504 total
  • Tax Payment

    Common Stock

    2025-05-15$22.70/sh430$9,76134,074 total
  • Tax Payment

    Common Stock

    2025-05-15$22.70/sh1,255$28,48937,206 total
  • Exercise/Conversion

    Restricted Stock Unit

    2025-05-154740 total
    Common Stock (474 underlying)
  • Tax Payment

    Common Stock

    2025-05-15$22.70/sh136$3,08733,001 total
  • Tax Payment

    Common Stock

    2025-05-15$22.70/sh47$1,06732,663 total
  • Exercise/Conversion

    Common Stock

    2025-05-15+4,38738,461 total
  • Exercise/Conversion

    Restricted Stock Unit

    2025-05-151,5036,012 total
    Common Stock (1,503 underlying)
  • Exercise/Conversion

    Common Stock

    2025-05-15+47433,137 total
  • Exercise/Conversion

    Restricted Stock Unit

    2025-05-151620 total
    Common Stock (162 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2025-05-154,3878,774 total
    Common Stock (4,387 underlying)
Footnotes (12)
  • [F1]The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 18, 2024, through May 15, 2025. This transaction is also exempt under Rule 16b-3(c).
  • [F10]RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
  • [F11]Awarded on May 23, 2024 pursuant to the 2023 Plan.
  • [F12]RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
  • [F2]Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
  • [F3]Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).
  • [F4]Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
  • [F5]RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.
  • [F6]Awarded on May 25, 2022 pursuant to the 2013 Plan.
  • [F7]RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
  • [F8]Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
  • [F9]Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.

Issuer

TANDEM DIABETES CARE INC

CIK 0001438133

Entity typeother

Related Parties

1
  • filerCIK 0001582970

Filing Metadata

Form type
4
Filed
May 18, 8:00 PM ET
Accepted
May 19, 6:06 PM ET
Size
26.2 KB